Holaira Closes $42 Million Round – Investment led by Vertex Venture Holdings to Support Randomized Clinical Trial

03 April 2014

Minneapolis, MN, April 03, 2014 – Holaira, Inc., a developer of medical devices to treat obstructive lung diseases, today announced the completion of its Series D private equity financing, totaling $42 million led by Vertex Venture Holdings Ltd. Other participants in this financing round include Windham Venture Partners, two strategic investors, and all of Holaira’s […]

Continue Reading

Ivantis Completes a $46.5 MM Financing; Company Receives Approval to Expand US Pivotal Trial for Novel Glaucoma Device

13 January 2014

One of the largest medical device financings of the past year in the US; funds will support multiple clinical trials, including recently expanded US pivotal trial for novel glaucoma device IRVINE, Calif.–(BUSINESS WIRE)–Ivantis, developer of the novel Hydrus® Microstent device designed to lower eye pressure for glaucoma patients, announced today that it secured an additional […]

Continue Reading